Imfinzi, also known as durvalumab, is a groundbreaking drug that has revolutionized the treatment of certain types of cancer. This medication belongs to a class of drugs called immune checkpoint inhibitors, which work by helping the body’s immune system recognize and attack cancer cells.

Imfinzi is primarily used in the treatment of non-small cell lung cancer (NSCLC) and bladder cancer. It is often prescribed for patients whose cancer has spread or cannot be surgically removed. Imfinzi works by blocking a protein called PD-L1, which cancer cells use to evade detection by the immune system. By blocking this protein, Imfinzi helps the immune system recognize and destroy cancer cells.

Like all medications, Imfinzi can cause side effects. Common side effects of Imfinzi include fatigue, cough, rash, and nausea. More serious side effects, such as immune-related reactions, can also occur. It is important to discuss any concerns or side effects with your healthcare provider.

Before starting treatment with Imfinzi, it is important to discuss your medical history and any other medications you are taking with your healthcare provider. They will be able to determine if Imfinzi is the right treatment option for you.

Overall, Imfinzi has shown great promise in improving outcomes for patients with certain types of cancer. If you have been diagnosed with NSCLC or bladder cancer, talk to your healthcare provider about whether Imfinzi may be a suitable treatment option for you.